Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin with Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice.
Qiongyu Hao, Susanne M Henning, Clara E Magyar, Jonathan Said, Jin Zhong, Matthew B Rettig, Jaydutt V Vadgama, Piwen Wang
Article in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
7 citing papers in PubMed, 8 citations in OpenAlex.
Qiongyu HaoDivision of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.ORCID 0000-0002-4720-767X
Susanne M HenningCenter for Human Nutrition, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Clara E MagyarDepartment of Pathology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Jonathan SaidDepartment of Pathology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Jin ZhongVA Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA.
Matthew B RettigDepartments of Medicine and Urology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
Jaydutt V VadgamaDivision of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.ORCID 0000-0002-0019-8622
Piwen WangDivision of Cancer Research and Training, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA.
University of California, Los Angeles · USUniversity of California, Riverside · US
Funding
UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Sustaining Faculty Development & Community EngagementS21MD000103 · NIMHD · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI CARLISLE, DAVID M · 2001 to 2015
$73.9M
Workshop for Junior Biostatisticians in Health ResearchU54MD007598 · NIMHD · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI Piwen Wang · 2012 to 2026
$60.0M
UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
Supporting African American Churches to Promote Cancer ScreeningU54CA143931 · NCI · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI VADGAMA, JAYDUTT V. · 2009 to 2022
$19.7M
Signaling mediators of CCL2/CCR2 and natural product discoveryR35GM149318 · NIGMS · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI Piwen Wang · 2023 to 2026
$1.4M
Co-targeting obesity in prostate cancer chemoprevention and therapySC1GM121202 · NIGMS · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI WANG, PIWEN · 2019 to 2022
$1.4M
Increased chemoprevention by a mixture of three phytochemicals in prostate cancerR03CA208221 · NCI · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI WANG, PIWEN · 2017 to 2018
The low bioavailability of most phytochemicals limits their anticancer effects in humans. The present study was designed to test whether combining arctigenin (Arc), a lignan mainly from the seed of
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin with Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice. · full record | OpenQuestion